3 US Penny Stocks With Market Caps Over 30M To Consider - Yahoo Finance

EPRSQDelisted Stock  USD 0.0001  0.00  0.00%   
Slightly above 56% of EPIRUS Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading EPIRUS Biopharmaceuticals pink sheet suggests that many investors are alarmed at this time. EPIRUS Biopharmaceutica's investing sentiment overview a quick insight into current market opportunities from investing in EPIRUS Biopharmaceuticals. Many technical investors use EPIRUS Biopharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
3 US Penny Stocks With Market Caps Over 30M To Consider Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

EPIRUS Biopharmaceutica Fundamental Analysis

We analyze EPIRUS Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EPIRUS Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EPIRUS Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

EPIRUS Biopharmaceutica is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

EPIRUS Biopharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EPIRUS Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of EPIRUS Biopharmaceutica could also be used in its relative valuation, which is a method of valuing EPIRUS Biopharmaceutica by comparing valuation metrics with similar companies.

Peers

EPIRUS Biopharmaceutica Related Equities

OPTOpthea   13.08   
0%
100.0%
GLTOGalecto   12.28   
0%
93.0%
FBRXForte Biosciences   8.78   
0%
67.0%
GNTAGenenta Science   4.45   
0%
34.0%
MLYSMineralys Therapeutics,   4.30   
0%
32.0%
PHVSPharvaris   2.20   
0%
16.0%
CNTACentessa Pharmaceuticals   1.34   
0%
10.0%
PEPGPepGen   1.01   
0%
7.0%
MOLNMolecular Partners   0.57   
0%
4.0%
HLVXHillevax   0.53   
0%
4.0%
ERASErasca   0.52   
3.0%
0%
NAMSWNewAmsterdam Pharma   0.56   
4.0%
0%
ANTXAN2 Therapeutics   0.79   
6.0%
0%
EWTXEdgewise Therapeutics   0.91   
6.0%
0%
STROSutro Biopharma   1.01   
7.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in EPIRUS Pink Sheet

If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.